Clinical Trial

Low-cost Imaging Technology for Global Prevention of Cervical Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2025 (before its estimated August 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
Cervical cancer remains the first or second leading cause of cancer death among women in many low-and middle-income countries. Cervical cancer prevention programs in low-resource settings are hampered by a lack of personnel with appropriate clinical expertise, lack of pathology services, and lack of associated infrastructure. There is an urgent need for appropriate diagnostic tools to enable accurate screening and diagnosis in low-resource settings. The purpose of this study is to develop and validate a low-cost Multimodal Mobile Colposcope (MMC) for global cervical cancer prevention programs. This new device will combine the imaging capabilities of a mobile colposcope with the microscopic imaging capabilities of a fiber-optic confocal imaging probe.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-10-04; most recent amendment 2025-02-04.
Trial Details
NCT Number NCT05078528
Lead Sponsor Barretos Cancer Hospital
Collaborators: William Marsh Rice University, M.D. Anderson Cancer Center, Irmandade Santa Casa de Misericórdia de Porto Alegre
Conditions Cervical Intraepithelial Neoplasia
Enrollment 1,060 participants
Start Date 2021-09-20
Primary Completion 2025-08-03 (estimated)
Study Completion 2025-12-03 (estimated)
Updated on ClinicalTrials.gov 2025-02-06